{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"inclusion-body-myositis","columns":[{"gene":"","key":"population-0282f2d011a48bc7c911","label":"Inclusion body myositis","mondoId":"MONDO:0007827","onsetQualifier":null,"originColumnKey":"MONDO:0007827/OMIM:147421","originalViews":[{"key":"MONDO:0007827/OMIM:147421","label":"Inclusion body myositis","scopeLabel":"OMIM:147421","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["03fe1962ee119bea9a0c0ab0b167117768ef44b00691c8acbf07d5a010adabb3","3fe387b319b74a2e30e99d06e16f099ed4bb08ca2b2a6406d88f851c89907707","8f2530cf7e38c7c5f2055305be06d24fcf1d233c66246c44f866bc1b691ee943","e69ef13192ebff0a60c864f4da40161f275cff99c9a946a8ff226a5f9d3a6170","e78d4f7904996d697d7af218d6917c1e88b844d62b6a741e92350ee486e2fbfe","ee7f7936f3297f116b789526d64a818e2676291b51e7199753a67011591997e7"],"recordQualifiers":{},"scopeLabel":"OMIM:147421","sourceIds":["OMIM:147421"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."},{"gene":"","key":"population-58a24a8c0d24ead9af50","label":"Inclusion body myositis","mondoId":"MONDO:0007827","onsetQualifier":null,"originColumnKey":"MONDO:0007827/ORPHA:611","originalViews":[{"key":"MONDO:0007827/ORPHA:611","label":"Inclusion body myositis","scopeLabel":"ORPHA:611","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["285337555df861b7bc428c7f055473b9746db3973cb0868c375da8112097efe4","585da48561fcdaabbf90e009653c3e9226e6bf1190794e9d8beb933510ce27fa","5d994dede4e243eaa926a5856d5e538e29cec7d46ad59a9d2f6715d91dff86df","693e5b5a6b7d180bbfec0f8fa309aea5087456b7c843e64f9aa1957c8ba91ccb","7b02c3eb42a4848f0c5fd84cac9f16cf39114b3cbac0a1749011932be9041848","902246d65875b678269dcb42e1b2cea78317bf3873ec0549a5ffde66d2e29f10","9f26627686b1f5fb744eb02d9f42fa28c0edb3da573b2cc1ce474a961933763d","9f6d0942a52d55f57e12088b0585b7c068e1bce97b61d4a2224f57c0406891ef","a05b3c0efd3175038b480254c47cca0973b5c07b3d6adbb2b147ec0541318723","a503f346b121fbcaa73ea205b139f1ad92aa268573405ee75dc74c07d6f33402","bf38450bbfdb3ed9d490048ab10736914eea6966c27074275be40aa14601e0e8","c543ce7f4fa031f88140a3e7a097d4e2fe08f02076348f2f435288c42c724945","c89ccb76a13c696572866604d17e6195bac2091870b48b3236fb503e3886ba81","ea19624d3bdfc9ac449e04aaea45c18494b7e1ab49383a0e642597ae28aa63d6"],"recordQualifiers":{},"scopeLabel":"ORPHA:611","sourceIds":["ORPHA:611"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0282f2d011a48bc7c911","population-58a24a8c0d24ead9af50"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004303","HP:0034153","HP:0002960","HP:0001315","HP:0002460","HP:0002015","HP:0003236"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"omim":6,"orphanet":14}},"features":[{"hpoId":"HP:0004303","label":"Abnormal muscle fiber morphology","primary":true},{"hpoId":"HP:0034153","label":"Anti-cytosolic-5-nucleotidase-1A antibody positivity","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":true},{"hpoId":"HP:0001315","label":"Diminished deep tendon reflex","primary":true},{"hpoId":"HP:0002460","label":"Distal muscle weakness","primary":true},{"hpoId":"HP:0002015","label":"Dysphagia","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0003457","label":"EMG abnormality","primary":false},{"hpoId":"HP:0008872","label":"Feeding difficulties in infancy","primary":false},{"hpoId":"HP:0001265","label":"Hyporeflexia","primary":false},{"hpoId":"HP:0009071","label":"Inflammatory myopathy","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false},{"hpoId":"HP:0003731","label":"Quadriceps muscle weakness","primary":false},{"hpoId":"HP:0003200","label":"Ragged-red muscle fibers","primary":false},{"hpoId":"HP:0003805","label":"Rimmed vacuoles","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false}],"ledeHtml":"Inclusion body myositis (IBM) is a progressive muscle disorder characterized by muscle inflammation, weakness, and atrophy (wasting). It is a type of inflammatory myopathy. The most common symptoms include progressive weakness of the legs, arms, fingers, and wrists. Some people also have weakness of the facial muscles (especially muscles controlling eye closure), or difficulty swallowing (dysphagia). Muscle cramping and pain are uncommon, but have been reported in some people. The underlying cause of IBM is poorly understood and likely involves the interaction of genetic, immune-related, and environmental factors. Some people may have a genetic predisposition to developing IBM, but the condition itself typically is not inherited.","mondoId":"MONDO:0007827","node":{"canonicalSlug":"inclusion-body-myositis","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Inclusion body myositis","originalSourceId":"ORPHA:611","paragraphs":["Inclusion body myositis (IBM) is a progressive muscle disorder characterized by muscle inflammation, weakness, and atrophy (wasting). It is a type of inflammatory myopathy. The most common symptoms include progressive weakness of the legs, arms, fingers, and wrists. Some people also have weakness of the facial muscles (especially muscles controlling eye closure), or difficulty swallowing (dysphagia). Muscle cramping and pain are uncommon, but have been reported in some people. The underlying cause of IBM is poorly understood and likely involves the interaction of genetic, immune-related, and environmental factors. Some people may have a genetic predisposition to developing IBM, but the condition itself typically is not inherited."],"rawAttribution":"MONDO:0007827","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:05Z","upstream":"GARD:0003896","url":"https://rarediseases.info.nih.gov/diseases/3896"},"ownColumnKeys":["population-0282f2d011a48bc7c911","population-58a24a8c0d24ead9af50"],"publication":"published","relationships":[{"kind":"parent","label":"myositis disease","mondoId":"MONDO:0021167","slug":null},{"kind":"child","label":"myopathy, proximal, and ophthalmoplegia","mondoId":"MONDO:0011577","slug":"myopathy-proximal-and-ophthalmoplegia"},{"kind":"child","label":"GNE myopathy","mondoId":"MONDO:0011603","slug":"gne-myopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"03fe1962ee119bea9a0c0ab0b167117768ef44b00691c8acbf07d5a010adabb3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:147421","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003805","is_excluded":false,"label":"Rimmed vacuoles","onset_id":null,"reference":"OMIM:147421","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"285337555df861b7bc428c7f055473b9746db3973cb0868c375da8112097efe4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003200","is_excluded":false,"label":"Ragged-red muscle fibers","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3fe387b319b74a2e30e99d06e16f099ed4bb08ca2b2a6406d88f851c89907707","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:147421","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"OMIM:147421","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"585da48561fcdaabbf90e009653c3e9226e6bf1190794e9d8beb933510ce27fa","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034153","is_excluded":false,"label":"Anti-cytosolic-5-nucleotidase-1A antibody positivity","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5d994dede4e243eaa926a5856d5e538e29cec7d46ad59a9d2f6715d91dff86df","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009071","is_excluded":false,"label":"Inflammatory myopathy","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"693e5b5a6b7d180bbfec0f8fa309aea5087456b7c843e64f9aa1957c8ba91ccb","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002960","is_excluded":false,"label":"Autoimmunity","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7b02c3eb42a4848f0c5fd84cac9f16cf39114b3cbac0a1749011932be9041848","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003457","is_excluded":false,"label":"EMG abnormality","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8f2530cf7e38c7c5f2055305be06d24fcf1d233c66246c44f866bc1b691ee943","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:147421","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002460","is_excluded":false,"label":"Distal muscle weakness","onset_id":null,"reference":"OMIM:147421","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"902246d65875b678269dcb42e1b2cea78317bf3873ec0549a5ffde66d2e29f10","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004303","is_excluded":false,"label":"Abnormal muscle fiber morphology","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f26627686b1f5fb744eb02d9f42fa28c0edb3da573b2cc1ce474a961933763d","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f6d0942a52d55f57e12088b0585b7c068e1bce97b61d4a2224f57c0406891ef","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a05b3c0efd3175038b480254c47cca0973b5c07b3d6adbb2b147ec0541318723","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003731","is_excluded":false,"label":"Quadriceps muscle weakness","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a503f346b121fbcaa73ea205b139f1ad92aa268573405ee75dc74c07d6f33402","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003805","is_excluded":false,"label":"Rimmed vacuoles","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bf38450bbfdb3ed9d490048ab10736914eea6966c27074275be40aa14601e0e8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c543ce7f4fa031f88140a3e7a097d4e2fe08f02076348f2f435288c42c724945","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008872","is_excluded":false,"label":"Feeding difficulties in infancy","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c89ccb76a13c696572866604d17e6195bac2091870b48b3236fb503e3886ba81","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001315","is_excluded":false,"label":"Diminished deep tendon reflex","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e69ef13192ebff0a60c864f4da40161f275cff99c9a946a8ff226a5f9d3a6170","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:147421","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"OMIM:147421","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e78d4f7904996d697d7af218d6917c1e88b844d62b6a741e92350ee486e2fbfe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:147421","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0009071","is_excluded":false,"label":"Inflammatory myopathy","onset_id":null,"reference":"OMIM:147421","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ea19624d3bdfc9ac449e04aaea45c18494b7e1ab49383a0e642597ae28aa63d6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:611","disease_name":"Inclusion body myositis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"ORPHA:611","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ee7f7936f3297f116b789526d64a818e2676291b51e7199753a67011591997e7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:147421","disease_name":"Inclusion body myositis","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001265","is_excluded":false,"label":"Hyporeflexia","onset_id":null,"reference":"OMIM:147421","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3896\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007827\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0003896</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Inclusion body myositis (IBM) is a progressive muscle disorder characterized by muscle inflammation, weakness, and atrophy (wasting). It is a type of inflammatory myopathy. The most common symptoms include progressive weakness of the legs, arms, fingers, and wrists. Some people also have weakness of the facial muscles (especially muscles controlling eye closure), or difficulty swallowing (dysphagia). Muscle cramping and pain are uncommon, but have been reported in some people. The underlying cause of IBM is poorly understood and likely involves the interaction of genetic, immune-related, and environmental factors. Some people may have a genetic predisposition to developing IBM, but the condition itself typically is not inherited.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3896\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"inclusion-body-myositis","sourceDocuments":[{"name":"GARD: Inclusion body myositis","reviewed":null,"source_release":"2026-10-25T03:39:05Z","url":"https://rarediseases.info.nih.gov/diseases/3896"},{"name":"MONDO: inclusion body myositis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007827"}],"sourceNote":"","synonyms":["IBM","inclusion body myositis","inflammatory myopathy","sIBM","Sporadic Inclusion Body Myositis","sporadic inclusion body myositis"],"takeawayHtml":"","title":"inclusion body myositis"},"schemaVersion":1}
